Osteoporosis and inflammation

N. Hamdy (Leiden, Netherlands)

Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Number: 12
Disease area: Airway diseases

PDF journal article, handout or slidesSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Hamdy (Leiden, Netherlands). Osteoporosis and inflammation. Research Seminar 2006 - Complexity of patients with multiple chronic diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007


Determinants of success
Source: Eur Respir J 2011; 38: 1215-1218
Year: 2011



The role of inflammation in cachexia
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006



Why is it important to consider (sub)phenotypes of asthma and COPD?
Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not?
Year: 2005

COPD coronary/peripheral vascular disease
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006



Implications for disease and therapy
Source: Annual Congress 2005 - Oxidative and nitrative stress: control of cell function in COPD
Year: 2005

Phenotypic markers of asthma and COPD at the tissue level
Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not?
Year: 2005

Complex chronic comorbidities of COPD
Source: Eur Respir J 2008; 31: 204-212
Year: 2008



The role of inflammation in COPD
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006



Serum and skeletal muscle leptin in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2005 - Systemic effects of COPD
Year: 2005


b-Lactams and the lung
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=64
Year: 2004

Subphenotyping COPD: is it relevant for therapeutic intervention and disease outcome?
Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not?
Year: 2005

Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Source: Eur Respir J 2008; 31: 1334-1356
Year: 2008



Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations
Source: Annual Congress 2005 - COPD: role of infection
Year: 2005


Clinical value of C-reactive protein in severe acute exacerbations of COPD
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005


Small airways diseases, excluding asthma and COPD: an overview
Source: Eur Respir Rev 2013; 22: 131-147
Year: 2013



Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: 325-331
Year: 2002



Desmosin as a marker for tissue injury in COPD
Source: Annual Congress 2007 - α1-Antitrypsin deficiency: molecular and clinical news
Year: 2007